Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Viganò L; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Locatelli A; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ulisse A; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Galbardi B; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Tosi D; Institut régional du Cancer de Montpellier (ICM), Montpellier, France., Tacchetti C; Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan, Italy., Daniele T; Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan, Italy., Győrffy B; Department of Bioinformatics, Faculty of General Medicine, Semmelweis University, Budapest, Hungary.; 2nd Dept. of Pediatrics, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; TTK Oncology Biomarker Research Group, Institute of Enzymology, Budapest, Hungary., Sica L; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Macchini M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Zambetti M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Zambelli S; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bianchini G; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 13; Vol. 28 (10), pp. 2167-2179.
Autor:
Ziccheddu B; Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy.; Multiple Myeloma Program, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida., Da Vià MC; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Lionetti M; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Maeda A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Morlupi S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Todoerti K; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Oliva S; Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy., D'Agostino M; Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy., Corradini P; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Clinical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Landgren O; Multiple Myeloma Program, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Iorio F; Centre for Computational Biology, Human Technopole, Milan, Italy.; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Cambridge, United Kingdom., Pettine L; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Pompa A; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Manzoni M; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Baldini L; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Neri A; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Maura F; Multiple Myeloma Program, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida. fxm557@med.miami.edu niccolo.bolli@unimi.it.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Bolli N; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. fxm557@med.miami.edu niccolo.bolli@unimi.it.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Dec 01; Vol. 27 (23), pp. 6479-6490. Date of Electronic Publication: 2021 Sep 15.
Autor:
Guardia C; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Arpí-LLucià O; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Menendez S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Casadevall D; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Servitja S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Montero JC; Centro de Investigación del Cáncer, IBSAL-CSIC-CIBERONC, Salamanca, Spain., Soria-Jiménez L; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Sabbaghi M; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Peña R; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Madoz-Gúrpide J; Department of Pathology, IIS-Fundación Jiménez Díaz-CIBERONC, Madrid, Spain., Lloveras B; Department of Pathology, Hospital del Mar, Barcelona, Spain., Lluch A; INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia-CIBERONC, Universitat de València, Barcelona, Spain., Eroles P; INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia-CIBERONC, Universitat de València, Barcelona, Spain.; INCLIVA, Biomedical Research Institute, Valencia, Spain., Arribas J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Pandiella A; Centro de Investigación del Cáncer, IBSAL-CSIC-CIBERONC, Salamanca, Spain., Gianni L; Fondazione Gianni Bonadonna, Milan, Italy., Rojo F; Department of Pathology, IIS-Fundación Jiménez Díaz-CIBERONC, Madrid, Spain., Rovira A; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Albanell J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. jalbanell@hospitaldelmar.cat.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 15; Vol. 27 (18), pp. 5096-5108. Date of Electronic Publication: 2021 Aug 12.